Health
BioNTech/Pfizer vaccine is less potent against South African variant – Financial Times
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
The BioNTech/Pfizer Covid-19 vaccine appears to be significantly less effective against the virus variant that emerged in South Africa, according to a study published on Wednesday.
The vaccine still works against the strain known as 501Y.V2, but the shot produced only a third of the antibodies that it did for the original virus in a lab study using an engineered virus.
The partners said there was “no clinical evidence” that people vaccinated with their Covid-19 shot lacked protection against the…
-
Noosa News22 hours agoRallies under way as nationwide support for Palestine surges
-
General21 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General24 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General19 hours agoThousands flood cities demanding action on Palestine